Approval · Notice of Compliance 3818 · 1997
FLUVOXAMINE: Notice of Compliance 3818
Issued October 29, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3818
- Date
- October 29, 1997
- Company
- Laboratoires Pro Doc Limitée
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antidepressant, antiobsessional agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUVOXAMINE | 02236753 | Cancelled Post Market |
| FLUVOXAMINE | 02236754 | Cancelled Post Market |
Medicinal ingredients
- FLUVOXAMINE MALEATE 50 MG per TAB
- FLUVOXAMINE MALEATE 100 MG per TAB